TIVOLZA Trademark

Trademark Overview


On Monday, October 7, 2024, a trademark application was filed for TIVOLZA with the United States Patent and Trademark Office. The USPTO has given the TIVOLZA trademark a serial number of 98789277. The federal status of this trademark filing is REQUEST FOR EXTENSION OF TIME TO FILE OPPOSITION as of Thursday, April 10, 2025. This trademark is owned by Regeneron Pharmaceuticals, Inc.. The TIVOLZA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, metabolic, hematological, immunological, inflammatory, oncological, ophthalmological, neurological, musculoskeletal, bone, connective tissue, dermatological, infectious, autoimmune, nephrological, hepatological, allergic, genetic, respiratory, and viral diseases and disorders
tivolza

General Information


Serial Number98789277
Word MarkTIVOLZA
Filing DateMonday, October 7, 2024
Status802 - REQUEST FOR EXTENSION OF TIME TO FILE OPPOSITION
Status DateThursday, April 10, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 18, 2025

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, metabolic, hematological, immunological, inflammatory, oncological, ophthalmological, neurological, musculoskeletal, bone, connective tissue, dermatological, infectious, autoimmune, nephrological, hepatological, allergic, genetic, respiratory, and viral diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 7, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRegeneron Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Party NameRegeneron Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Trademark Events


Event DateEvent Description
Tuesday, October 8, 2024NEW APPLICATION ENTERED
Tuesday, October 8, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 3, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, November 23, 2024ASSIGNED TO EXAMINER
Tuesday, December 3, 2024NON-FINAL ACTION WRITTEN
Tuesday, December 3, 2024NON-FINAL ACTION E-MAILED
Monday, February 24, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 24, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, February 24, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 25, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 12, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 18, 2025PUBLISHED FOR OPPOSITION
Thursday, April 10, 2025EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, March 18, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED